Sci-Tech Today Bhutan
SEE OTHER BRANDS

Get your fresh news on science and technology in Bhutan

Sci-Tech Today Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today Bhutan.

Press releases published on July 11, 2025

Milestone Pharmaceuticals Announces Proposed Public Offering

Milestone Pharmaceuticals Announces Proposed Public Offering

MONTREAL, Quebec and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST) today announced that it has commenced an underwritten public offering (the “Offering”) of its common shares, accompanying  …

Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray

Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray

New PDUFA Action Date of December 13, 2025 $75 Million Royalty Purchase Agreement Payment from RTW Extended Through 2025 MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) (Milestone) today …

Aurora Mobile Evaluates Solana (SOL) for its Cryptocurrency Treasury Strategy

Aurora Mobile Evaluates Solana (SOL) for its Cryptocurrency Treasury Strategy

SHENZHEN, China, July 11, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, today announced that it is evaluating the …

e-therapeutics reduziert Risiken im klinischen Verfahren für GalOmic-Kandidaten ETX-312 dank positiver Ergebnisse in der vorklinischen Phase

e-therapeutics reduziert Risiken im klinischen Verfahren für GalOmic-Kandidaten ETX-312 dank positiver Ergebnisse in der vorklinischen Phase

ETX-312 wurde in GLP-konformen Toxikologiestudien in überhöhten Dosierungen gut vertragen GMP-konforme Herstellung einer Charge für klinische Studien erfolgreich abgeschlossen Auf Kurs für die Einreichung bei der CTA im vierten Quartal 2025 LONDON, July 11 …

e-therapeutics sécurise le développement clinique de son candidat GalOmic ETX-312 grâce à des données non cliniques positives

e-therapeutics sécurise le développement clinique de son candidat GalOmic ETX-312 grâce à des données non cliniques positives

ETX-312 bien toléré à des doses élevées lors d’études de toxicologie conformes aux normes BPL Fabrication du lot destiné à l’essai clinique achevée avec succès conformément aux normes BPF Soumission de la demande d’autorisation d’essai clinique en bonne …

Italfarmaco Presents New Cardiac Data for Givinostat at 16th European Paediatric Neurology Society (EPNS) Congress

Italfarmaco Presents New Cardiac Data for Givinostat at 16th European Paediatric Neurology Society (EPNS) Congress

In total, 11 abstracts on givinostat were accepted for presentation at the Congress, including two for an oral presentation   MILAN, Italy, July 11, 2025 – Italfarmaco S.p.A. announced today that new cardiac data for givinostat, a novel histone deacetylase …

Ripple partners with Bank of New York Mellon, XRP soars - LET Mining launches new cloud mining strategy for XRP holders

Ripple partners with Bank of New York Mellon, XRP soars - LET Mining launches new cloud mining strategy for XRP holders

New York City, July 10, 2025 (GLOBE NEWSWIRE) -- Ripple has established a partnership with the oldest bank on Wall Street, and BNY Mellon has become the custodian of RLUSD, which will take Ripple's stablecoin strategy to the next level and herald its long- …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service